Laboratory of Experimental Ophthalmology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
JAMA Ophthalmol. 2013 Apr;131(4):481-5. doi: 10.1001/jamaophthalmol.2013.2368.
A multifocal intraocular lens (MFIOL) allows for spectacle independence after cataract surgery and is thus a seemingly attractive option. However, several optical limitations have been reported or can be hypothesized.
To evaluate the influence of an MFIOL on standard automated perimetry (SAP) size III and size V test results.
Cross-sectional case-control.
The University Medical Center Groningen and the Nij Smellinghe Hospital Drachten, the Netherlands.
Sixteen eyes of 16 patients with a diffractive MFIOL (median age, 64 years), 18 phakic eyes of 18 healthy individuals serving as controls (median age, 62 years), and 12 eyes of 12 patients with a monofocal IOL (median age, 64 years) were included.
All participants underwent (1) SAP using a 30-2 grid and the Swedish Interactive Threshold Algorithm standard strategy with stimulus size III and (2) a full threshold test with stimulus size V.
Primary outcome measures were the mean deviation (MD) for size III and the mean sensitivity (MS) for size V. Comparisons between groups were adjusted for age and pupil size. RESULTS For SAP size III, the average difference in MD between patients in the MFIOL group and phakic controls was -2.40 dB (P < .001) and between patients in the monofocal IOL group and phakic controls was -0.32 dB (P = .52). For SAP size V, the corresponding differences in MS were -1.61 dB (P = .002) and -0.80 dB (P = .09), respectively. The differences were essentially independent of eccentricity for both SAP size III and SAP size V.
Patients with a diffractive MFIOL have a clinically relevant reduction of the visual sensitivity as assessed with SAP size III and size V. The reduction seems to be related to the multifocal design of the IOL rather than to pseudophakia. The reduction interferes with the assessment of common eye diseases such as glaucoma and comes on top of the decline of visual sensitivity due to normal aging or age-related eye diseases, thus potentially accelerating visual impairment.
多焦点人工晶状体(MFIOL)可实现白内障手术后的脱镜视力,因此是一种颇具吸引力的选择。然而,已经报道或可以假设存在多种光学局限性。
评估 MFIOL 对标准自动视野计(SAP)III 型和 V 型测试结果的影响。
横断面病例对照研究。
荷兰格罗宁根大学医学中心和尼尔斯明赫林厄医院。
16 名患者的 16 只眼,这些患者均植入了折射性 MFIOL(中位年龄 64 岁);18 名健康个体的 18 只未植入人工晶状体的眼作为对照(中位年龄 62 岁);12 名植入单焦点 IOL 的患者的 12 只眼(中位年龄 64 岁)也纳入研究。
所有参与者均接受(1)使用 30-2 网格和瑞典互动阈值算法标准策略进行 SAP,使用 III 型刺激大小,以及(2)使用 V 型刺激大小进行全阈值测试。
主要观察指标为 III 型刺激大小的平均偏差(MD)和 V 型刺激大小的平均敏感度(MS)。对各组间的比较进行了年龄和瞳孔大小的调整。
对于 SAP III 型刺激大小,MFIOL 组患者与未植入人工晶状体对照组之间的 MD 平均差异为-2.40dB(P<.001),单焦点 IOL 组患者与未植入人工晶状体对照组之间的 MD 平均差异为-0.32dB(P=.52)。对于 SAP V 型刺激大小,相应的 MS 差异分别为-1.61dB(P=.002)和-0.80dB(P=.09)。对于 SAP III 型和 SAP V 型刺激大小,这些差异基本上与离焦无关。
患有折射性 MFIOL 的患者在 SAP III 型和 V 型刺激大小测试中表现出显著的视觉敏感度降低。这种降低似乎与 IOL 的多焦点设计有关,而不是与后房型人工晶状体有关。这种降低会干扰青光眼等常见眼病的评估,并且叠加在正常衰老或与年龄相关的眼病导致的视觉敏感度下降之上,从而可能加速视力损伤。